Screening breast MRI and gadolinium deposition: cause for concern?
CH Neal - Journal of Breast Imaging, 2022 - academic.oup.com
Gadolinium-based contrast agents (GBCAs) have been used worldwide for over 30 years
and have enabled lifesaving diagnoses. Contrast-enhanced breast MRI is frequently used …
and have enabled lifesaving diagnoses. Contrast-enhanced breast MRI is frequently used …
Gadolinium retention and breast MRI screening: more harm than good?
F Sardanelli, A Cozzi, RM Trimboli… - American Journal of …, 2020 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to describe the risk-benefit balance of contrast-
enhanced breast MRI (CE-BMRI) screening. CONCLUSION. CE-BMRI confers risk of effects …
enhanced breast MRI (CE-BMRI) screening. CONCLUSION. CE-BMRI confers risk of effects …
Brain MRI and clinical exam findings in women with multiple gadolinium-based contrast agent (GBCA) exposures due to screening breast MRIs
Objectives Multiple exposures to gadolinium-based contrast agents (GBCAs) is known to be
associated with gadolinium deposition in the brain in certain patients. Such deposition has …
associated with gadolinium deposition in the brain in certain patients. Such deposition has …
Breast Lesion Detection and Characterization at Contrast-enhanced MR Mammography: Gadobenate Dimeglumine versus Gadopentetate Dimeglumine1
PURPOSE: To prospectively and intraindividually compare equivalent (0.1 mmol per
kilogram of body weight) doses of gadobenate dimeglumine and gadopentetate …
kilogram of body weight) doses of gadobenate dimeglumine and gadopentetate …
Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for breast MR imaging …
L Martincich, M Faivre-Pierret, CM Zechmann… - Radiology, 2011 - pubs.rsna.org
Purpose To intraindividually compare 0.1 mmol/kg doses of gadobenate dimeglumine and
gadopentetate dimeglumine for contrast material–enhanced breast magnetic resonance …
gadopentetate dimeglumine for contrast material–enhanced breast magnetic resonance …
Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine
F Pediconi, C Catalano, S Padula… - American Journal of …, 2008 - Am Roentgen Ray Soc
OBJECTIVE. The objective of our study was to intraindividually compare 0.1 mmol/kg doses
of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced breast …
of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced breast …
Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced …
DM Renz, T Durmus, J Böttcher, M Taupitz… - Investigative …, 2014 - journals.lww.com
Objective In contrast to conventional breast imaging techniques, one major diagnostic
benefit of breast magnetic resonance imaging (MRI) is the simultaneous acquisition of …
benefit of breast magnetic resonance imaging (MRI) is the simultaneous acquisition of …
Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine
MV Knopp, MW Bourne, F Sardanelli… - American Journal of …, 2003 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study was to evaluate the clinical efficacy and dose
response relationship of three doses of gadobenate dimeglumine for MRI of the breast and …
response relationship of three doses of gadobenate dimeglumine for MRI of the breast and …
[HTML][HTML] Breast cancer screening programs: does one risk fit all?
F Pediconi, F Galati - Quantitative Imaging in Medicine and Surgery, 2020 - ncbi.nlm.nih.gov
© Quantitative Imaging in Medicine and Surgery. All rights reserved. Quant Imaging Med
Surg 2020; 10 (4): 886-890| http://dx. doi. org/10.21037/qims. 2020.03. 14 screening for high …
Surg 2020; 10 (4): 886-890| http://dx. doi. org/10.21037/qims. 2020.03. 14 screening for high …
Preliminary study: Breast cancers can be well seen on 3T breast MRI with a half-dose of gadobutrol
AN Melsaether, E Kim, E Mema, J Babb, SG Kim - Clinical imaging, 2019 - Elsevier
Background Dynamic contrast enhanced (DCE) breast MRI is highly sensitive for breast
cancer and requires gadolinium-based contrast agents (GBCA) s, which have potential …
cancer and requires gadolinium-based contrast agents (GBCA) s, which have potential …